We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

45 hedge funds and large institutions have $18.4M invested in Agile Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 49 → 45 (-4)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

40% less capital invested

Capital invested by funds: $30.5M → $18.4M (-$12.2M)

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
12
Reduced
11
Closed
14
Calls
$177K
Puts
–
Net Calls
+$177K
Net Calls Change
-$138K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.79M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$275K
4
VF
Virtu Financial
New York
+$148K
5
GCP
GSA Capital Partners
United Kingdom
+$104K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$563K
2
Morgan Stanley
Morgan Stanley
New York
-$310K
3
NIM
Needham Investment Management
New York
-$272K
4
E
Ergoteles
New York
-$203K
5
FMBTD
First Midwest Bank Trust Division
Illinois
-$124K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$10K -$4.23K -3 -23%
FCMT
27
Founders Capital Management (Texas)
Texas
$10K +$9.87K +7 +233%
ASN
28
Advisory Services Network
Georgia
$10K +$15.5K +11 New
TRCT
29
Tower Research Capital (TRC)
New York
$9K +$12.7K +9 New
Victory Capital Management
30
Victory Capital Management
Texas
$7K +$1.41K +1 +17%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$6K -$563K -399 -99%
HF
32
HRT Financial
New York
$6K -$69.1K -49 -88%
Simplex Trading
33
Simplex Trading
Illinois
$5K -$5.64K -4 -40%
CWM
34
Centric Wealth Management
Illinois
$5K – – –
Creative Planning
35
Creative Planning
Kansas
$5K – – –
PFM
36
Parsec Financial Management
North Carolina
$5K – – –
Janney Montgomery Scott
37
Janney Montgomery Scott
Pennsylvania
$5K +$7.05K +5 New
Citigroup
38
Citigroup
New York
$4K – – –
ACM
39
Aquatic Capital Management
Illinois
$2K +$2.82K +2 New
CAPTRUST Financial Advisors
40
CAPTRUST Financial Advisors
North Carolina
$2K +$2.82K +2 New
RFA
41
Reilly Financial Advisors
California
$2K +$2.82K +2 New
UBS Group
42
UBS Group
Switzerland
$2K +$2.82K +2 New
Carson Wealth (CWM LLC)
43
Carson Wealth (CWM LLC)
Nebraska
$2K +$4.23K +3 New
Wells Fargo
44
Wells Fargo
California
$1K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$903 – – –
E
46
Ergoteles
New York
– -$203K -106 Closed
SGI
47
Summit Global Investments
Utah
– -$121K -63 Closed
DBIA
48
Dumont & Blake Investment Advisors
New Jersey
– -$67K -35 Closed
CS
49
Candriam SCA
Luxembourg
– -$28K -15 Closed
RJA
50
Raymond James & Associates
Florida
– -$25K -13 Closed
1
2
3

AGRX Hedge Fund Activity: Q4 2021 in Review

45 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q4 2021, worth a combined $18.4M — down 40% from $30.5M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AGRX and 10 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 12 added.

The largest buyer was Perceptive Advisors, adding an estimated $3.79M. The largest seller was Royal Bank of Canada, cutting an estimated $563K.

  • 45 institutional investors held Agile Therapeutics (AGRX) as of Q4 2021, down from 49 in Q3 2021.
  • Funds reported $18.4M of Agile Therapeutics stock for Q4 2021, down 40% quarter-over-quarter.
  • 10 funds opened new Agile Therapeutics positions in Q4 2021 and 14 closed out, a net change of -4 holders.
  • The largest Agile Therapeutics buyer in Q4 2021 was Perceptive Advisors, an estimated $3.79M added.
  • The largest Agile Therapeutics seller in Q4 2021 was Royal Bank of Canada, an estimated $563K sold.

Based on aggregated 13F filings for Q4 2021.